News

Feliza Mirasol is the science editor for 

Articles

CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.

Exothera Partners with Remedium to Scale-Up Manufacturing of Gene Therapy Drug Candidate

PharmaBlock has opened a new R&D facility in Pennsylvania, expanding its capacity to deliver GMP projects. 

PharmaBlock Opens New R&D Facility in Pennsylvania

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.

Scorpius BioManufacturing Announces New Microbial Capacity and New Interim President

The combined solutions are currently available on the market.

TrakCel and Lonza Reach Integration Milestone to Combine Cell and Gene Therapy Manufacturing, Orchestration Solutions 

The services are based on the company’s PurePrep EasyClean (PEC) orthogonal peptide purification technology.

PurePep EasyClean Services Set to Accelerate Development and Manufacturing of Peptide-based Drugs 

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Sartorius and Teknova Team Up for Gene Therapy Process Development

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

Samsung Biologics to Build Plant 5 as Part of Capacity Expansion to Bio Campus II

Grant Playter is the Assistant Editor for 

Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development.

Polyplus Introduces Novel LNP Formulation for Use in mRNA Therapeutics

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.

Supplier News